| characteristics |
Total
n = 194 |
HIV
n = 129 |
HIV/HCV
n = 65 |
P < |
| ALT U/L (range) |
28.0 (10-175) |
24 (10-171) |
43 (13-175) |
0.0001 |
| AST U/L (range) |
24.0 (10-281) |
22 (10-80) |
41 (13-281) |
0.0001 |
| Total-cholesterol (mg/dL) ± SD |
195.2±51.7 |
208.8 ± 47.1 |
165.7 ± 49.9 |
0.0001 |
| HDL-cholesterol (mg/dL ) ± SD |
50.7±17.4 |
51.7 ± 14.8 |
46.5 ± 19.3 |
0.05 |
| LDL-cholesterol (mg/dL) ± SD |
124.2±45.4 |
133.5 ± 42.8 |
90.3 ± 36.1 |
0.0001 |
| Triglicerides (mg/dL) (range) |
132 (35-637) |
134 (35-637) |
121.5 (52-429) |
ns |
| Triglicerides/HDL ratio |
2.7 (0.5-14) |
2.5 (0.5-20) |
3.2 (0.7-14) |
ns |
| Calcium (mg/dL) |
9.2±0.51 |
9.1 ± 0.6 |
9.2 ± 0.5 |
ns |
| Phosphorus (mg/dL)* |
3.2±0.6 |
3.2 ± 0.6 |
3.2 ± 0.8 |
ns |
| Parathyroid hormone (pg/mL)° |
37.0 (11-362) |
37.1 (12-119) |
36 (11-362) |
ns |
| Bone alkaline phosphatase (IU/L)¶ |
46.5 (17.2-170) |
46.8 (17.2-116) |
46.2 (17.4-170) |
ns |
| 25-Hydroxyvitamin D (ng/mL) |
18.4 (3-88.3) |
16.7 (3-68) |
27.2 (4.8-88.3) |
0.0001 |
| HCV-RNA (UI/mL) > 700.000 (n, %) |
- |
- |
41 (63) |
- |
| CD4+ T-cell count (cells/μL) (range) |
480 (34-1338) |
533.5 (34-1082) |
413.5 (10-1338) |
0.01 |
| Nadir CD4+ T-cell count <200 (cells/μL) |
136 (70.1) |
88 (68) |
49 (75) |
ns |
| Detectable HIV-RNA (n, %) |
54 (57.4) |
30 (23.2) |
24 (36.9) |
ns |
HIV: Human Immunodeficiency Virus; HCV: Hepatitis C Virus; ALT: Alanine Aminotransferase; AST: Aspartate Aminotransferase; HDL: High-Density Lipoprotein; LDL: Low-
Density Lipoprotein; ns: Not Significant.*Missing in 10 HIV mono-infected and 2 HIV/HCV co-infected patients; °Missing in 6 HIV mono-infected and 3 HIV/HCV co-infected
patients; Missing in 5 HIV mono-infected patients.